4/4
12:39 pm
gkos
The Inner Circle acknowledges, Greg Kunst as a Pinnacle Professional Member Inner Circle of Excellence [Yahoo! Finance]
Low
Report
The Inner Circle acknowledges, Greg Kunst as a Pinnacle Professional Member Inner Circle of Excellence [Yahoo! Finance]
3/11
07:21 am
gkos
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution [Yahoo! Finance]
Low
Report
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution [Yahoo! Finance]
3/11
07:00 am
gkos
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
Low
Report
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
2/24
12:36 pm
gkos
FDA accepts Glaukos application for Epioxa for keratoconus [Seeking Alpha]
Low
Report
FDA accepts Glaukos application for Epioxa for keratoconus [Seeking Alpha]
2/24
07:00 am
gkos
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
Low
Report
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
2/23
09:49 am
gkos
We're Not Worried About Glaukos' (NYSE:GKOS) Cash Burn [Yahoo! Finance]
Low
Report
We're Not Worried About Glaukos' (NYSE:GKOS) Cash Burn [Yahoo! Finance]
2/21
10:51 am
gkos
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline [Yahoo! Finance]
Medium
Report
GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline [Yahoo! Finance]
2/21
10:28 am
gkos
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
2/21
10:28 am
gkos
Glaukos: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Glaukos: Q4 Earnings Snapshot [Yahoo! Finance]
2/21
10:28 am
gkos
Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... [Yahoo! Finance]
Medium
Report
Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... [Yahoo! Finance]
2/21
09:32 am
gkos
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Wells Fargo & Company from $153.00 to $160.00. They now have an "overweight" rating on the stock.
Medium
Report
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Wells Fargo & Company from $153.00 to $160.00. They now have an "overweight" rating on the stock.
2/21
08:13 am
gkos
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Needham & Company LLC from $149.00 to $176.00. They now have a "buy" rating on the stock.
Medium
Report
Glaukos Co. (NYSE: GKOS) had its price target raised by analysts at Needham & Company LLC from $149.00 to $176.00. They now have a "buy" rating on the stock.
2/21
04:32 am
gkos
https://seekingalpha.com/article/4760603-glaukos-corporation-gkos-q4-2024-earnings-call-transcript [Seeking Alpha]
High
Report
https://seekingalpha.com/article/4760603-glaukos-corporation-gkos-q4-2024-earnings-call-transcript [Seeking Alpha]
2/20
07:17 pm
gkos
What To Expect From Glaukos Corp (GKOS) Q4 2024 Earnings [Yahoo! Finance]
Medium
Report
What To Expect From Glaukos Corp (GKOS) Q4 2024 Earnings [Yahoo! Finance]
2/20
04:05 pm
gkos
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results
High
Report
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results
2/19
10:01 am
gkos
Electronic Arts initiated, Workday downgraded: Wall Street's top analyst calls [Yahoo! Finance]
Medium
Report
Electronic Arts initiated, Workday downgraded: Wall Street's top analyst calls [Yahoo! Finance]
2/19
07:06 am
gkos
Glaukos Co. (NYSE: GKOS) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $200.00 price target on the stock, up previously from $140.00.
Medium
Report
Glaukos Co. (NYSE: GKOS) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $200.00 price target on the stock, up previously from $140.00.
2/7
10:02 pm
gkos
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now [Yahoo! Finance]
Low
Report
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now [Yahoo! Finance]
2/6
08:14 am
gkos
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar? [Yahoo! Finance]
Low
Report
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar? [Yahoo! Finance]
2/5
06:27 am
gkos
iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia [Yahoo! Finance]
Low
Report
iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia [Yahoo! Finance]
1/27
09:55 am
gkos
Glaukos Co. (NYSE: GKOS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $180.00 price target on the stock, up previously from $140.00.
Low
Report
Glaukos Co. (NYSE: GKOS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $180.00 price target on the stock, up previously from $140.00.
1/23
07:00 am
gkos
Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
Low
Report
Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
1/14
04:05 pm
gkos
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
Low
Report
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
1/8
05:34 pm
gkos
Glaukos Reaches 52-Week High: What's Driving the Stock's Rally? [Yahoo! Finance]
Low
Report
Glaukos Reaches 52-Week High: What's Driving the Stock's Rally? [Yahoo! Finance]